Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...

Process mining and representation learning applied to 447,222 patients revealed nuanced pre-diagnostic pathways associated with delayed MS diagnosis, implicating referral friction, misdiagnosis ...

TIEBREAKER BASIS FOR TWO-WAY TIES: TIEBREAKER BASIS FOR MULTI-WAY TIES: Ties for playoff positions (including division winners) will be broken utilizing the criteria set forth in subparagraph a. below ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

For more than 40 years, investors have trusted Morningstar to tell it like it is. Our independent analysis and investment research tools uncover how well an investment serves investors—and no one else ...